Literature DB >> 888258

Diabetic maculopathy.

J W McMeel, C L Trempe, E B Franks.   

Abstract

The incidence, pathogenesis, and treatment of diabetic maculopathy are discussed. A plea is made for earlier, more discrete treatment that may improve the chances of prolonging sharp central vision.

Entities:  

Mesh:

Year:  1977        PMID: 888258

Source DB:  PubMed          Journal:  Trans Sect Ophthalmol Am Acad Ophthalmol Otolaryngol        ISSN: 0161-6978


  6 in total

1.  Subthreshold diode micropulse photocoagulation for the treatment of clinically significant diabetic macular oedema.

Authors:  J K Luttrull; D C Musch; M A Mainster
Journal:  Br J Ophthalmol       Date:  2005-01       Impact factor: 4.638

2.  Panretinal photocoagulation induces pro-inflammatory cytokines and macular thickening in high-risk proliferative diabetic retinopathy.

Authors:  Masahiko Shimura; Kanako Yasuda; Toru Nakazawa; Toshiaki Abe; Takashi Shiono; Tomohiro Iida; Taiji Sakamoto; Kohji Nishida
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-07-29       Impact factor: 3.117

3.  A randomized, placebo-controlled clinical trial of intravitreal triamcinolone for refractory diabetic macular edema.

Authors:  Mohammad H Dehghan; Hamid Ahmadieh; Alireza Ramezani; Morteza Entezari; Arash Anisian
Journal:  Int Ophthalmol       Date:  2007-06-23       Impact factor: 2.031

4.  Panretinal-Photocoagulation before Pars Plana Vitrectomy Influences Vitreous Level of Interleukin-6 but not of Vascular Endothelial Growth Factor in Patients with Diabetic Retinopathy.

Authors:  Masahiko Shimura; Kanako Yasuda; Toru Nakazawa; Takashi Shiono; Kohji Nishida
Journal:  Int J Biomed Sci       Date:  2007-03

5.  Association of retinopathy and intima media thickness of common carotid artery in type 2 diabetic patients.

Authors:  Ali Momeni; Mohamad Ali Dyani; Elnaz Ebrahimi; Morteza Sedehi; Afsaneh Naderi
Journal:  J Res Med Sci       Date:  2015-04       Impact factor: 1.852

6.  Two year result of intravitreal bevacizumab for diabetic macular edema using treat and extend protocol.

Authors:  Masahiko Sugimoto; Atsushi Ichio; Takayasu Nunome; Mineo Kondo
Journal:  Medicine (Baltimore)       Date:  2017-04       Impact factor: 1.889

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.